Clinical Trial

Investigating the Transcutaneous vs. Transcranial Mechanisms of Trigeminal Nerve Stimulation (eTNS) Using fMRI

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 18, 2026 (before its estimated July 5, 2026 completion). Its status may not reflect the trial's current state.
Summary
Transcutaneous Trigeminal Nerve Stimulation (eTNS) is a non-invasive technique that modulates brain activity by applying electrical currents to the forehead. However, it remains unclear whether its effects are primarily driven by activating peripheral nerves in the skin (the transcutaneous pathway) or by the electrical current passing directly through the skull into the brain (the transcranial pathway). This study aims to differentiate these two mechanisms in healthy volunteers. Participants will complete two separate MRI scanning sessions. In one session, a local anesthetic (lidocaine) will be applied to numb the skin over the forehead (specifically the supraorbital nerve branch) to temporarily block the peripheral nerve signals. In the other session, no anesthesia will be used. During both sessions, participants will receive active direct current eTNS (DC-eTNS) and a sham (inactive) stimulation while inside a 3T MRI scanner. Researchers will simultaneously measure brain activity (fMRI) and physiological signals (breathing and heart rate). By comparing the brain and bodily responses between the anesthetized and non-anesthetized conditions, the study seeks to determine exactly how eTNS signals travel to and affect the brainstem, cortex, and autonomic nervous system.
Trial Details
NCT Number NCT07657260
Lead Sponsor Xidian University
Conditions Healthy Volunteers, Neurophysiology, fMRI Research
Enrollment 25 participants
Start Date 2026-06-21
Primary Completion 2026-07-05 (estimated)
Study Completion 2026-07-05 (estimated)
Updated on ClinicalTrials.gov 2026-06-18